alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with this Amended Quarterly Report of Force Minerals Corporation (the “Company”) on Form 10-Q/A for the period ending August 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tim DeHerrera, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:  (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.    /s/Tim DeHerrera By: Tim DeHerrera Principal Executive Officer and Principal Financial Officer Dated: October21, 2013  A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32.1

Written Statement of the Chief Executive Officer and Chief Financial Officer

Pursuant to
Section 906

of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

The undersigned, the Chief Executive Officer and the Chief Financial Officer of Emergency Medical Services Corporation, a Delaware corporation (the
Company), each hereby certifies that, to his knowledge on the date hereof:



| | (a) | the Form 10-Q/A of the Company for the fiscal quarter ended June 30, 2006, filed on the date hereof with the Securities and Exchange Commission (the Report),
fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (b) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



/s/ William A. SangerWilliam A. SangerChief Executive Officer August 16,
2006/s/ Randel G. OwenRandel G. OwenChief Financial Officer August 16,
2006
##### 



Exhibit 10.16
 AMENDMENT NO. 2
TO
AMENDED AND RESTATED SECOND SUPPLEMENT
TO THE MASTER LOAN AGREEMENT
(REVOLVING LOAN)
 Second Amendment US
BIO WOODBURY, LLC, Borrower AGSTAR FINANCIAL
SERVICES, PCA Lender
 RECITALS
 MLA First Supplement Second Supplement Third Supplement Fourth
Supplement Loan Agreement
    AGREEMENT




---



##### 



. Modification of Second Supplement .
 a.
    
    Section #2 of the Second Supplement is hereby amended and restated to read as
follows:Revolving Loan Commitment. On the terms and conditions set forth
in the MLA and this Second Supplement, Lender agrees to make one or more
advances (collectively, the Revolving Loan) to the Borrower, during the
period beginning on the effective date of this Second Amendment and ending
on the Business Day immediately preceding the Maturity Date (as hereinafter
defined in Section 2 of the Second Supplement) (the Termination Date), in
an aggregate principal amount outstanding at any one time not to exceed
$3,500,000.00 (the Revolving Loan Commitment) provided, however,that at
no time shall the Outstanding Revolving Advance exceed the Borrowing Base.
The Revolving Loan Commitment shall expire at 12:00 noon Central time on
October 29, 2008 (the Revolving Loan Maturity Date). Subject to Section 7
of the Second Supplement, under the Revolving Loan Commitment amounts
borrowed and repaid or prepaid may be reborrowed at any time prior to and
including the Termination Date.
 Conditions to Effectiveness of this Amendment .
 Representations and Warranties .
   Miscellaneous .
 Effect; Ratification
 2




---



##### 



Loan Documents
 Counterparts
 Severability
 GOVERNING LAW
 WAIVER OF JURY TRIAL
  3




---



##### 



AMENDMENT NO. 2 TO
AMENDED AND RESTATED SECOND SUPPLEMENT TO THE MASTER LOAN AGREEMENT
(REVOLVING LOAN)
  BORROWER:
 US BIO WOODBURY, LLC,
 By:
    
    /s/ Kelly S. LangleyKelly S. LangleyIts: Treasurer
 LENDER:
 AGSTAR FINANCIAL SERVICES, PCA,
 By:
    
    /s/ Mark SchmidtMark SchmidtIts: Vice President
 4
---

Exhibit 32.1

CERTIFICATION PURSUANT TO18 U.S.C. § 1350, AS
ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF
2002

In connection with the Quarterly Report of Xeno Transplants
Corporation (the Company) on Form 10-QSB for the period ended March 31, 2008
as filed with the Securities and Exchange Commission on the date hereof (the
Report), I, Elliot Lebowitz, Executive Officer of the Company, certify,
pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

| | (1) | The Report fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
  and                                   
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------
| |     |                                                                                                                                                                 
| | (2) | The information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of the Company.

|May 14, 2008 | /s/
      Elliot Lebowitz            
|------------ | -------------------------------------
|             | Elliot Lebowitz                      
|             | President and Chief Executive Officer
|             | (Principal Executive Officer)        

---
#### STATE of Louisiana v. Rene DAIRIES.

No. 88-KH-1433.

Supreme Court of Louisiana.

June 13, 1988.

In re Dairies, Rene; applying for supervisory and/or remedial writs; Parish of Orleans, Criminal District Court, Div. “D”, No. 317-050; to the Court of Appeal, Fourth Circuit, No. 88KW-0857.

Denied. Stay order denied.
#### Westchester County Correction Officers Benevolent Association, Inc., Appellant, v County of Westchester, Respondent.

Appeal by the plaintiff, as limited by its brief, from stated portions of a judgment of the Supreme Court, Westchester County (Coppola, J.), entered October 25, 1989.

Ordered that the judgment is affirmed insofar as appealed from, with costs, for reasons stated by Justice Coppola at the Supreme Court. Thompson, J. P., Eiber, Miller and Ritter, JJ., concur.
* Pursuant to 5TH CIR. R. 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

November 9, 2005

Charles R. Fulbruge III

Clerk

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 05-51048

Summary Calendar

 

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

MARINO SANCHEZ,

Defendant-Appellant.

--------------------

Appeal from the United States District Court

for the Western District of Texas

USDC No. 3:04-CR-2564-ALL

--------------------

Before REAVLEY, GARZA, and BENAVIDES, Circuit Judges. 

PER CURIAM:*

Appealing the Judgment in a Criminal Case, Marino Sanchez

raises arguments that are foreclosed by Almendarez-Torres v.

United States, 523 U.S. 224, 235 (1998), which held that a prior

conviction is a sentencing factor under 8 U.S.C. § 1326(b)(2) and

not a separate criminal offense. The Government’s motion for

summary affirmance is GRANTED, and the judgment of the district

court is AFFIRMED.
Exhibit 32.2

Section 906 Certification

In connection with the quarterly report on Form 10-Q of NCI, Inc. (the Company)
for the fiscal quarter ended September 30, 2006, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned Senior Vice President and Chief Financial Officer of the Company certifies, to
the best of her knowledge and belief pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ---------------------------------------------------------------------------------------------------------------------



|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                       |  |                                                                                            
|---------------------- |  | -------------------------------------------------------------------------------------------
|Date: November 7, 2006 |  | /s/ Judith L. Bjornaas                                                                     
|                       |  | Judith L. Bjornaas                                                                         
|                       |  | Senior Vice President, Chief Financial Officer (Principal Financial and Accounting Officer)

A signed original of the written statement required by Section 906 has been provided to NCI, Inc. and will be
retained by NCI, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
EXHIBIT
32.1





CERTIFICATION
OF CHIEF EXECUTIVE OFFICER


PURSUANT
TO


18 U.S.C.
SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002








I, Jason
Smart, Chief Executive Officer of Zandaria Ventures, Inc., (the "Company"),
hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to my
knowledge:





(1) The
Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2009, as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and





(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





/s/
Jason
Smart


Jason
Smart


Chief
Executive Officer





Date:
August 14, 2009


-------------------
 This  certification  accompanies  the  Report  pursuant  to  Section  906
of the Sarbanes-Oxley  Act of 2002 and  shall not be
deemed  filed by the  Company  for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended.
 
 A
signed  original of this
written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of
this written  statement required by Section 906,  has
been  provided to the Company and will be retained by the Company and
furnished to the  Securities  and
Exchange  Commission or its staff upon
request.
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 2192 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                S. 2192

            To extend the reduction of duty on Azoxystrobin.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 29, 2009

  Mr. Vitter introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
            To extend the reduction of duty on Azoxystrobin.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. AZOXYSTROBIN.

    (a) In General.--Heading 9902.12.51 of the Harmonized Tariff 
Schedule of the United States (relating to Azoxystrobin) is amended--
            (1) in the general rate of duty column, by striking 
        ``6.17%'' and inserting ``4.7%''; and
            (2) in the effective period column, by striking ``12/31/
        2009'' and inserting ``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
<PAGE>



                                                                    EXHIBIT 24.2

              AMERICAN EXPRESS RECEIVABLES FINANCING CORPORATION II

                                POWER OF ATTORNEY

       American  Express  Receivables   Financing  Corporation  II,  a  Delaware
corporation (the "Company"),  and each of the undersigned officers and directors
of the  Company,  hereby  constitute  and  appoint  John D.  Koslow,  Leslie  R.
Scharfstein  and Stephen P. Norman,  jointly and  severally,  with full power of
substitution and revocation, their true and lawful attorneys-in-fact and agents,
for them and on their behalf and in their respective  names,  places and steads,
in any and all  capacities,  to sign,  execute and affix their  respective  seal
thereto and file any of the documents referred to below relating to the American
Express Credit Account Master Trust;  all filings and reports required under the
Securities  Exchange  Act of 1934,  including  Current  Reports  on Form 8-K and
Annual Reports on Form 10-K,  including any amendments thereto, on behalf of the
Company, with any regulatory authority,  granting unto said attorneys,  and each
of them, full power and authority to do and perform each and every act and thing
requisite  and  necessary  to be done in and  about  the  premises  in  order to
effectuate  the same as fully to all intents and purposes as they might or could
do if  personally  present,  hereby  ratifying  and  confirming  all  that  said
attorneys-in-fact  and agents,  or any of them,  may  lawfully do or cause to be
done by virtue hereof.

       This Power of Attorney may be executed in counterparts.

       IN WITNESS WHEREOF, American Express Receivables Financing Corporation II
has caused this Power of  Attorney  to be executed in its name by its  President
and attested by its Secretary,  and the undersigned  officers and directors have
hereunto set their hand as of the 27th day of March, 2003.

                                                  AMERICAN EXPRESS RECEIVABLES
                                                  FINANCING CORPORATION II

                                                  By: /s/ Leslie R. Scharfstein
                                                      -------------------------
                                                      Leslie R. Scharfstein
                                                      President

ATTEST:

/s/  Michael Kuchs
------------------------------
Michael Kuchs
Secretary




<PAGE>



/s/  Leslie R. Scharfstein
------------------------------
Leslie R. Scharfstein
President
(Principal Executive Officer)



/s/  John D. Koslow
------------------------------
John D. Koslow
Vice President and Treasurer
(Principal Finance Officer and
Principal Accounting Officer)



/s/ Donald J. Puglisi
------------------------------
Donald J. Puglisi
Director




/s/ David Yowan
------------------------------
David Yowan
Director
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 95-2449
FRANK EVANS, Plaintiff - Appellant,
versus RIVER RIDERS, INCORPORATED, a West Virginia Corporation, Defendant - Appellee, and MARK GRIMES, President/owner, River Riders, Incorporated; PETER LIGOCKI, a/k/a Carp, Defendants.

No. 95-2558
FRANK EVANS, Plaintiff - Appellee,
versus RIVER RIDERS, INCORPORATED, a West Virginia Corporation; MARK GRIMES, President/owner, River Riders, Incorporated; PETER LIGOCKI, a/k/a Carp, Defendants - Appellants.2Appeals from the United States District Court for the Northern District of West Virginia, at Martinsburg. Frederick P. Stamp, Jr., Chief District Judge. (CA-93-31-3) Submitted: January 23, 1996 Decided: January 31, 1996 Before MURNAGHAN and WILLIAMS, Circuit Judges, and PHILLIPS, Senior Circuit Judge. No. 95-2449 affirmed and No. 95-2558 dismissed by unpublished per curiam opinion. Frank Evans, Appellant Pro Se. Anita Rose Casey, MEYER, DARRAGH, BUCKLER, BEBENEK & ECK, Charleston, West Virginia, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).3 PER CURIAM: In Appeal No. 95-2449, Appellant appeals from the district court's order dismissing his personal injury action. We have reviewed the record and the district court's opinions and find no reversible error. Accordingly, we affirm on the reasoning of the district court. Evans v. River Riders, Inc. , No. CA-93-31-3 (N.D.W. Va. June 21, 1995). We further deny Appellant's motion to stay the action and Appellee's motion to dismiss the action. In Appeal No. 95-2558, the Appellants, Defendants below, noted this appeal outside the time period established by Fed. R. App. P. 4(a)(3), failed to obtain an extension of the appeal period and are not entitled to relief under Fed. R. App. P. 4(a)(6). The timeperiods established by Fed. R. App. P. 4 are "mandatory and jurisdictional." Browder v. Director, Dep't of Corrections , 434 U.S. 257, 264 (1978) (quoting United States v. Robinson, 361 U.S. 220, 229 (1960)). The district court entered its order on June 21, 1995; Evans noted his appeal on July 20, 1995. Appellants' notice of appeal was filed on August 15, 1995. Under Fed. R. App. P. 4(a)(3), the Appellants had fourteen days from the date Evans noted his appeal to note their appeal. Appellants' failure to note a timely appeal or obtain an extension of the appeal period deprives this court of jurisdiction to consider this case. We therefore dismiss the appeal.4 We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

No. 95-2449 - AFFIRMED No. 95-2558 - DISMISSED
EXHIBIT 32.2

Certification of Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant To

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the report on Form 10-Q of NCI, Inc. (the Company) for
the fiscal quarter ended March 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned Executive Vice President and Chief Financial Officer of the Company certifies, to the
best of her knowledge and belief pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                  |  |  |  |                                                                                                       |  |  |  | 
|----------------- |  |  |  | ----------------------------------------------------------------------------------------------------- |  |  |  | 
|Date: May 8, 2009 |  |  |  | /s/    JUDITH L. BJORNAAS                                                                            
|                  |  |  |  | Judith L. Bjornaas Executive Vice
President and Chief Financial Officer (Principal
Financial Officer)

A signed original of the written statement required by Section 906 has been provided to NCI, Inc. and will be
retained by NCI, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5

<S>                                       <C>
<PERIOD-TYPE>                              12-MOS
<FISCAL-YEAR-END>                          APR-30-2000
<PERIOD-END>                               APR-30-2000
<CASH>                                      25,520,158
<SECURITIES>                                         0
<RECEIVABLES>                              238,088,782
<ALLOWANCES>                                 2,133,994
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                             303,258,828
<CURRENT-LIABILITIES>                                0
<BONDS>                                    254,860,955
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         5,567
<OTHER-SE>                                  30,120,280
<TOTAL-LIABILITY-AND-EQUITY>               303,258,828
<SALES>                                     40,276,227
<TOTAL-REVENUES>                            40,276,227
<CGS>                                       16,509,757
<TOTAL-COSTS>                               16,509,757
<OTHER-EXPENSES>                            16,706,264
<LOSS-PROVISION>                             6,414,572
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              4,666,984
<INCOME-TAX>                                 1,703,449
<INCOME-CONTINUING>                          2,963,535
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 2,963,535
<EPS-BASIC>                                       0.53
<EPS-DILUTED>                                     0.53


</TABLE>
CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





Pursuant
to 18 U.S.C. § 1350, as adopted pursuant to Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that
the Quarterly Report on Form 10-Q for the nine months ended September 30,
2009 of Majestic Oil & Gas, Inc. (the “Company”) fully complies with the
requirements of Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 and that the information contained in such Report fairly
presents, in all material respects, the financial condition and results of
operations of the Company.




/s/ Patrick MontalbanChief
      Executive OfficerChief
      Financial Officer





November
16, 2009





A signed
original of this written statement required by Section 906 has been provided to
Majestic Oil & Gas, Inc. and will be retained by Majestic Oil & Gas,
Inc. and furnished to the Securities and Exchange Commission or its staff upon
request.
#### Warren DAVIS, Appellant, v. STATE of Florida, Appellee.

Nos. 86-2870, 86-2871 and 86-2872.

District Court of Appeal of Florida, Second District.

June 1, 1988.

James Marion Moorman, Public Defender, Bartow, and Allyn Giambalvo, Asst. Public Defender, Clearwater, for appellant.

Robert A. Butterworth, Atty. Gen., Tallahassee, and Gary 0. Welch, Asst. Atty. Gen., Tampa, for appellee.

PER CURIAM.

Appellant was sentenced in excess of the guidelines range and the departure was not accompanied by written reasons. We, therefore, reverse the sentence and remand for resentencing. *See State v. Jackson,*478 So.2d 1054 (Fla.1985).

SCHEB, A.C.J., and SCHOONOVER and HALL, JJ., concur.